Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02807623 · ClinicalTrials.gov registry record · NA
Do NSAIDS or Executing Exercise Decrease Local Erythema, Site Swelling & Pain After INoculation
A NA study of Immune System and Related Disorders, sponsored by Womack Army Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 2
- Study locations
NCT02807623: Completed NA study of Immune System and Related Disorders, sponsored by Womack Army Medical Center.
NCT02807623 is a NA study of Immune System and Related Disorders that has completed, run by Womack Army Medical Center. The registered enrollment target is 300 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02807623, a NA study of Immune System and Related Disorders, has completed, sponsored by Womack Army Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this clinical investigation is to evaluate the efficacy and immunologic effects of a non-pharmacological exercise intervention (push-ups) compared to an oral NSAID (ibuprofen) and an oral placebo to decrease local injection site inflammation symptoms of delayed pain, erythema, and edema and any impact on serologic antibody immune response after influenza vaccine receipt.
Primary Outcome
Level of Pain will be measured by validated pain scale, using a scale of 0 ( best, no pain) to 10 (worst, as bad as imaginable, completely interferes).
Conditions Studied
Interventions
- DRUG Ibuprofen
- DRUG oral placebo
- BEHAVIORAL Compound Exercise of Push-ups
Study Locations (2)
Maryland
- Walter Reed National Military Medical Center - Bethesda
North Carolina
- Womack Army Medical Center - Fort Bragg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2016-09 |
| Est. Completion | 2018-12 |
| Phase | NA |
What the finished NCT02807623 record still lists
NCT02807623 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 1 condition, with Immune System and Related Disorders appearing as the primary indexed condition, and to 3 interventions - of which Ibuprofen is the first listed.
NCT02807623 reports a single indexed study location in Maryland, North Carolina.
Frequently Asked Questions
What is clinical trial NCT02807623 about?
NCT02807623 is a clinical study titled "Do NSAIDS or Executing Exercise Decrease Local Erythema, Site Swelling & Pain After INoculation". The purpose of this clinical investigation is to evaluate the efficacy and immunologic effects of a non-pharmacological exercise intervention (push-ups) compared to an oral NSAID (ibuprofen) and an oral placebo to decrease local injection site inflammation symptoms of delayed pain, erythema, and ede...
What is the current status of trial NCT02807623?
This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2016-09. Estimated completion is 2018-12.
What conditions does trial NCT02807623 study?
This clinical trial studies the following conditions: Immune System and Related Disorders.
What interventions are being tested in trial NCT02807623?
The interventions under investigation include: Ibuprofen (DRUG), oral placebo (DRUG), Compound Exercise of Push-ups (BEHAVIORAL).
Who is sponsoring clinical trial NCT02807623?
This trial is sponsored by Womack Army Medical Center, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02807623 being conducted?
This trial has 2 study locations across Maryland, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Immune System and Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02807623's enrollment target sits among peer trials
300 330th of 2000 higher than 1,630 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia